The partnership will be formalised through the Biologics Pharma Innovation Programme Singapore
Ingredients | 08/12/2022 | By Sudeep Soparkar
Actimed Therapeutics Ltd, a clinical stage company focused on bringing innovation to the treatment of muscle wasting disorders, announced the grant of a new UK Patent (GB 2593902 B) covering new salts of S-pindolol for use in the treatment or prevention of cachexia with an expiry date in 2040.
Ingredients | 05/05/2022 | By Sudeep Soparkar | 181
Pfizer is set to resume its late-stage clinical trials of a treatment for Duchenne muscular dystrophy after stopping in December because of a clinical hold.
Ingredients | 02/05/2022 | By Sudeep Soparkar | 119
The U.S. FDA has accepted Fennec Pharmaceuticals resubmitted new drug application (NDA) for Pedmark, a drug aimed at preventing hearing loss in children who receive platinum-based chemothera
Ingredients | 30/04/2022 | By Sudeep Soparkar | 119
The U.S. FDA has approved a new drug from BioXcel used to treat patients with schizophrenia or bipolar I or II disorder. BioXcel?s drug Igalmi was developed using the company?s artificial intelligence platform, marking a big step for the technology in the pharmaceutical industry, according to BioXcel.
Ingredients | 27/04/2022 | By Sudeep Soparkar | 161
The U.S. FDA is broadening the survey date for Regeneron Pharmaceuticals' COVID-19 immune response mixed drink back by 90 days. The choice was made after information showed it might assist with forestalling disease.
Ingredients | 16/04/2022 | By Sudeep Soparkar
Researchers from Indian Institute of Science Education and Research (IISER) Kolkata during their research have found that Neem extract derived from the bark of Neem tree has the antiviral properties against coronavirus and can be used to treat and reduce the spread of SARS-Cov-2 that is causing the deadly Covid-19 disease among the people
Ingredients | 06/03/2022 | By Darshana
The full integration of drug substance R&D and manufacturing follows a year after the company's acquisition of its Alnwick, UK site and provides a more streamlined approach from candidate selection through to commercialization. Quotient Sciences Translational Pharmaceutics approach combining manufacturing and clinical dosing at a single organization
Ingredients | 18/02/2022 | By Darshana | 130
With a view to attain self-reliance and reduce import dependence in critical APIs, the Centre has approved ?Production Linked Incentive (PLI) scheme for promotion of domestic manufacturing of critical Key Starting Materials (KSMs)/Drug Intermediates (DIs) and Active Pharmaceutical Ingredients (APIs) In India
Ingredients | 23/12/2021 | By Darshana | 155
The Russian Direct Investment Fund (RDIF) and Panacea Biotec have announced the supply of the first shipment out of one million doses of the second component (human adenovirus serotype 5) of the Russian Sputnik V coronavirus vaccine manufactured by Panacea Biotec for sale in India, the company said in a statement
Ingredients | 08/09/2021 | By Darshana | 174